Retroperitoneal lymph node dissection (RPLND) is among the methods used in the treatment of non-seminoma testicular cancers. It involves a complete or modified removal of the retroperitoneal lymph nodes, the site of the first metastases.
Prior to the introduction of chemotherapy, RPLND was the only treatment method following radical orchiectomy. Particularly due to the challenging nature and numerous complications of classic open RPLND, adjuvant chemotherapy is the method of choice in non-seminoma testicular cancers.
The introduction of a modified and nerve-sparing technique has reduced the rate of complications; however, open RPLND still remains a demanding surgical procedure. The laparoscopic technique of lymphadenectomy provides an excellent benefit in terms of intraoperative morbidity, has a lower rate of intraoperative complications and significantly improves the postoperative course.